Effect of induction chemotherapy on speech and swallowing function in patients with oral tongue cancer.
BACKGROUND
Swallowing physiology, diet, and patient-reported outcomes were evaluated after induction chemotherapy for oral tongue cancer.


METHODS
Fifteen of 23 patients enrolled in a phase II clinical trial of induction chemotherapy followed by surgical resection for oral tongue cancer underwent instrumental and perceptual analysis of speech and swallowing. Oropharyngeal swallow efficiency (OPSE) was calculated. Patient-reported outcomes were collected. We compared pre- and postchemotherapy results.


RESULTS
OPSE scores were not significantly different (p > .05) after induction chemotherapy; however, patient-reported swallowing and diet levels were significantly higher (p < .001 and p = .015, respectively). Diet levels improved from soft-chewable to full diet in most patients. Speech intelligibility did not change (p = .328).


CONCLUSIONS
It appears that induction chemotherapy has a negligible effect on speech and swallowing physiology but may provide symptomatic improvement of pain and swallowing after treatment. Further investigations are needed to corroborate these findings.
Barringer
Denise A
DA
Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Hutcheson
Katherine A
KA
Sturgis
Erich M
EM
Kies
Merrill S
MS
Lewin
Jan S
JS
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001466:Barium Sulfate; D016190:Carboplatin / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000601:surgery; D003287:Contrast Media; D003679:Deglutition / Q000502:physiology*; D004032:Diet; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement; D011446:Prospective Studies; D011788:Quality of Life; D013065:Speech Intelligibility / Q000502:physiology*; D013068:Speech Production Measurement; D011795:Surveys and Questionnaires; D014062:Tongue Neoplasms / Q000188:drug therapy* / Q000601:surgery
D000970:Antineoplastic Agents; D003287:Contrast Media; D001466:Barium Sulfate; D016190:Carboplatin